This question came up during an evening symposium I attended at the American Society of Nephrology Renal Week last November in Philadelphia. It resulted in some heated discussion. It is necessary to ...

Cardiovascular illnesses, such as high blood pressure and heart problems, are often treated with angiotensin-converting enzyme (ACE) inhibitors. The ACE inhibitors lower blood pressure by relaxing ...

London, UK - Despite their widespread use, angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs)?first-line therapy in diabetic kidney disease?have little or no ...

In this rapidly evolving setting, clinicians are weighing the alleged harm of continuing these medications in patients for whom ACE inhibitors and ARBs have known benefit against the harm to their ...

A long-running dispute as to the supremacy of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) in the treatment of cardiovascular disease should be put to bed ...

Please provide your email address to receive an email when new articles are posted on . In a review published in the Journal of the American College of Cardiology, four experts stated there is no ...

Patients with heart failure who start taking sacubitril/valsartan (Entresto; Novartis) do not appear to have a greater risk of angioedema than do those who opt for an ACE inhibitor or ARB instead, an ...